|
Sign In to gain access to subscriptions and/or personal tools.
|
Toxicology and Industrial Health, Vol. 15, No. 1-2,
80-93 (1999)
DOI: 10.1177/074823379901500108
The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro
Joseph Ostby
Endocrinology Branch, National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, North Carolina
William R. Kelce
Endocrinology Branch, National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, North Carolina, Monsanto Company, St. Louis, MO, USA
Christy Lambright
Endocrinology Branch, National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, North Carolina
Cynthia J. Wolf
Endocrinology Branch, National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, North Carolina
Peter Mann
Experimental Pathology Laboratories Inc., Research Triangle Park, North Carolina
L. Earl Gray, Jr.
Endocrinology Branch, National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, North Carolina, gray.earl{at}epamail.epa.gov
Procymidone is a dicarboximide fungicide structurally related to the well-characterized fungicide vinclozolin. Vinclozolin metabolites bind to mammalian androgen receptors (AR) and act as AR antagonists, inhibiting androgen-dependent gene expression in vivo and in vitro by inhibiting AR-binding to DNA. The current study was designed to determine if procymidone acted as an AR antagonist in vitro and to describe the dosage levels of procymidone that alter sexual differentiation in vivo. In vitro, procymidone inhibited androgen from binding the human AR (hAR) in COS (monkey kidney) cells transfected with hAR at 3.16 µM. In vitro, procymidone acted as an androgen antagonist, inhibiting dihydrotestosterone (DHT)-induced transcriptional activation at 0.2 µM in CV-1 cells (cotransfected with the hAR and a MMTV-luciferase reporter gene). In vivo, maternal procymidone exposure at 0, 25, 50, 100, or 200 mg kg–1 day–1 during gestation and early lactation (gestational day 14 to postnatal day 3) altered reproductive development of male offspring at all dosage levels tested. Male offspring exhibited shortened anogenital distance (at 25 mg kg–1 day–1 and above), permanent nipples, reduced weight of several androgen-dependent tissues (levator ani and bulbocavernosus muscles, prostate, seminal vesicles, Cowper's gland and glans penis), and malformations (hypospadias, cleft phallus, exposed os penis, vaginal pouch, hydronephrosis, occasional hydroureter, epididymal granulomas, and ectopic, undescended testes). In addition, perinatal procymidone treatment had a marked effect on the histology of the lateral and ventral prostatic and seminal vesicular tissues of the offspring (at 50 mg kg–1 day–1 and above). These effects consisted of fibrosis, cellular infiltration, and epithelial hyperplasia. This constellation of effects is similar to that produced by perinatal exposure to vinclozolin. However, procymidone appears to be slightly less potent in inducing malformations than vinclozolin by a factor of about two. In summary, the antiandrogenic activity of procymidone was demonstrated in vivo and in vitro in cell lines transfected with hAR. Since the role of androgens in mammalian sexual differentiation is highly conserved, it is likely that humans would be adversely affected by procymidone in a predictable manner if the human fetus was exposed to sufficient levels during critical stages of intrauterine and neonatal life.
Key Words: antiandrogen • binding • developmental reproductive toxicity • endocrine disruption • procymidone • sexual differentiation • transcriptional activation
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. B. Metzdorff, M. Dalgaard, S. Christiansen, M. Axelstad, U. Hass, M. K. Kiersgaard, M. Scholze, A. Kortenkamp, and A. M. Vinggaard
Dysgenesis and Histological Changes of Genitals and Perturbations of Gene Expression in Male Rats after In Utero Exposure to Antiandrogen Mixtures
Toxicol. Sci.,
July 1, 2007;
98(1):
87 - 98.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. T. Sanderson
The Steroid Hormone Biosynthesis Pathway as a Target for Endocrine-Disrupting Chemicals
Toxicol. Sci.,
November 1, 2006;
94(1):
3 - 21.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P R Dalsenter, G M Santana, S W Grande, A J. Andrade, and S L Araujo
Phthalate affect the reproductive function and sexual behavior of male Wistar rats
Human and Experimental Toxicology,
June 1, 2006;
25(6):
297 - 303.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K Svechnikov, V Supornsilchai, M-L Strand, A Wahlgren, D Seidlova-Wuttke, W Wuttke, and O Soder
Influence of long-term dietary administration of procymidone, a fungicide with anti-androgenic effects, or the phytoestrogen genistein to rats on the pituitary-gonadal axis and Leydig cell steroidogenesis
J. Endocrinol.,
October 1, 2005;
187(1):
117 - 124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. C. Noriega, J. Ostby, C. Lambright, V. S. Wilson, and L. E. Gray Jr.
Late Gestational Exposure to the Fungicide Prochloraz Delays the Onset of Parturition and Causes Reproductive Malformations in Male but Not Female Rat Offspring
Biol Reprod,
June 1, 2005;
72(6):
1324 - 1335.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Bowman, N. J. Barlow, K. J. Turner, D. G. Wallace, and P. M. D. Foster
Effects of in Utero Exposure to Finasteride on Androgen-Dependent Reproductive Development in the Male Rat
Toxicol. Sci.,
August 1, 2003;
74(2):
393 - 406.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Ma, B. Cotton, W. Lichtensteiger, and M. Schlumpf
UV Filters with Antagonistic Action at Androgen Receptors in the MDA-kb2 Cell Transcriptional-Activation Assay
Toxicol. Sci.,
July 1, 2003;
74(1):
43 - 50.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Nellemann, M. Dalgaard, H. R. Lam, and A. M. Vinggaard
The Combined Effects of Vinclozolin and Procymidone Do Not Deviate from Expected Additivity in Vitro and in Vivo
Toxicol. Sci.,
February 1, 2003;
71(2):
251 - 262.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Vinggaard, C. Nellemann, M. Dalgaard, E. B. Jorgensen, and H. R. Andersen
Antiandrogenic Effects in Vitro and in Vivo of the Fungicide Prochloraz
Toxicol. Sci.,
October 1, 2002;
69(2):
344 - 353.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. J. Turner, N. J. Barlow, M. F. Struve, D. G. Wallace, K. W. Gaido, D. C. Dorman, and P. M. D. Foster
Effects of in Utero Exposure to the Organophosphate Insecticide Fenitrothion on Androgen-Dependent Reproductive Development in the Crl:CD(SD)BR Rat
Toxicol. Sci.,
July 1, 2002;
68(1):
174 - 183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M.D. Foster and B. S. Mcintyre
Endocrine Active Agents: Implications of Adverse and Non-Adverse Changes
Toxicol Pathol,
January 1, 2002;
30(1):
59 - 65.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. J. Wolf, A. Hotchkiss, J. S. Ostby, G. A. LeBlanc, and L. E. Gray Jr.
Effects of Prenatal Testosterone Propionate on the Sexual Development of Male and Female Rats: A Dose-Response Study
Toxicol. Sci.,
January 1, 2002;
65(1):
71 - 86.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. S. McIntyre, N. J. Barlow, and P. M. D. Foster
Androgen-Mediated Development in Male Rat Offspring Exposed to Flutamide in Utero: Permanence and Correlation of Early Postnatal Changes in Anogenital Distance and Nipple Retention with Malformations in Androgen-Dependent Tissues
Toxicol. Sci.,
August 1, 2001;
62(2):
236 - 249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Tamura, S. C. Maness, K. Reischmann, D. C. Dorman, L. E. Gray, and K. W. Gaido
Androgen Receptor Antagonism by the Organophosphate Insecticide Fenitrothion
Toxicol. Sci.,
March 1, 2001;
60(1):
56 - 62.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. G. Parks, J. S. Ostby, C. R. Lambright, B. D. Abbott, G. R. Klinefelter, N. J. Barlow, and L. E. Gray Jr.
The Plasticizer Diethylhexyl Phthalate Induces Malformations by Decreasing Fetal Testosterone Synthesis during Sexual Differentiation in the Male Rat
Toxicol. Sci.,
December 1, 2000;
58(2):
339 - 349.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Gray Jr., J. Ostby, J. Furr, M. Price, D. N. R. Veeramachaneni, and L. Parks
Perinatal Exposure to the Phthalates DEHP, BBP, and DINP, but Not DEP, DMP, or DOTP, Alters Sexual Differentiation of the Male Rat
Toxicol. Sci.,
December 1, 2000;
58(2):
350 - 365.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Lambright, J. Ostby, K. Bobseine, V. Wilson, A. K. Hotchkiss, P. C. Mann, and L. E. Gray Jr.
Cellular and Molecular Mechanisms of Action of Linuron: An Antiandrogenic Herbicide that Produces Reproductive Malformations in Male Rats
Toxicol. Sci.,
August 1, 2000;
56(2):
389 - 399.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Mylchreest, D. G. Wallace, R. C. Cattley, and P. M. D. Foster
Dose-Dependent Alterations in Androgen-Regulated Male Reproductive Development in Rats Exposed to Di(n-butyl) Phthalate during Late Gestation
Toxicol. Sci.,
May 1, 2000;
55(1):
143 - 151.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Wolf, G. A. LeBlanc, J. S. Ostby, and L. E. Gray Jr.
Characterization of the Period of Sensitivity of Fetal Male Sexual Development to Vinclozolin
Toxicol. Sci.,
May 1, 2000;
55(1):
152 - 161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
